Boxes
0.1.1Key challenges for the future in financing health systems for UHC
0.2.2Defining efficiency, equity and quality in health care and systems
1.3.1Medical savings accounts are inefficient, inequitable and do not provide sufficient financial protection
1.3.2France demonstrates how difficult it is to achieve high levels of population coverage for complementary VHI covering user charges
3.1.1The role of information technology and digital health infrastructure for primary care payment models
3.1.2Payment methods for community pharmacists as their role expands to a first-contact point with the health system
3.4.2The role of public funding: COVID-19 vaccines and therapeutics
3.4.3Industry spending on lobbying, marketing and consolidation
3.4.4How do push and pull mechanisms work? Examples in the area of antimicrobial resistance (AMR)
3.6.2Summary of potential market failures in LTC and possible policy tools to mitigate them
3.10.1PDP case study: Medicines for Malaria Venture and Coartem